Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
PR Newswire
Report Store
UsernamePublicRestriction
Tags:
Regulation Cybersecurity Digital Health

Let’s Talk About Cybersecurity: US FDA Wants Feedback On Safety Alerts

  • News

Executive Summary

The FDA is convening a panel of experts in September to talk about how to craft cybersecurity communications that adequately alert patients about potential vulnerabilities while not creating a panic. The meeting comes as the agency has been putting out a growing number of cybersecurity alerts, including most recently a recall for certain vulnerable Medtronic insulin pumps.

Table

View full table

Advertisement

Related Content

Medtech Insight
Lack Of Funding Stalls Major US FDA Cybersecurity Initiative
Medtech Insight
Heartburn: Yet Another Device-Maker Is Facing Cardiac Device Cybersecurity Worries – This Time, It's Medtronic
Medtech Insight
US FDA Pushes Further On Cybersecurity Efforts Despite Limited Resources

Topics

Advertisement
Tags:
Regulation Cybersecurity Digital Health
UsernamePublicRestriction

Register

MT125343

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By